<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03495869</url>
  </required_header>
  <id_info>
    <org_study_id>HM20012559</org_study_id>
    <secondary_id>U54DA038999</secondary_id>
    <nct_id>NCT03495869</nct_id>
  </id_info>
  <brief_title>Feasibility and Validation of a Standard Phenotyping Assessment Battery</brief_title>
  <acronym>PhAB</acronym>
  <official_title>NIDA Phenotyping Assessments Battery (PhAB) Feasibility and Validation Study in Non-Intoxicated Drug Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Virginia Commonwealth University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of this project is to collect preliminary data on psychosocial measures and&#xD;
      behavioral performance comparing individuals with Opioid Use Disorder, Cocaine Use Disorder,&#xD;
      dual diagnosis of Opioid and Cocaine Use Disorder, and Healthy Controls in an effort to&#xD;
      determine overall feasibility of a phenotypic &quot;fingerprint&quot; for cohorts of individuals with&#xD;
      addictions for use during clinical trials.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is profound heterogeneity of subjects in clinical studies of addictions, with patients&#xD;
      being diagnosed by the primary substance of use. As a result, utilizing current DSM&#xD;
      addictions classification leads to problems with signal detection and hamper the progress of&#xD;
      the development of new drugs and treatments for substance use disorders (SUDs). Getting&#xD;
      beyond the DSM-5 based definitions is necessary to &quot;fingerprint&quot; addiction phenotypes and&#xD;
      endophenotypes, using machine-learning analyses of big data. A detailed in-depth assessment&#xD;
      of addiction phenotypes (deep phenotyping) may also include neuroimaging.&#xD;
&#xD;
      In an effort to develop a &quot;fingerprint&quot; for addiction phenotypes, NIDA established a&#xD;
      Workgroup to develop a phenotyping battery of tests and self-rated psychometric scales,&#xD;
      supplemented by resting state fMRI to be administered to participants in any extramural&#xD;
      clinical trial where addictions are assessed. The final phenotyping battery content was&#xD;
      determined via consensus from both the selected experts- consultants group and the NIDA&#xD;
      workgroup, and as such, the battery requires feasibility and validation study to finalize its&#xD;
      content. The NIDA Phenotyping Assessment Battery (PhAB) covers six neurofunctional addiction&#xD;
      domains: Metacognition, Interoception, Cognition/Executive Function, Reward/Incentive&#xD;
      Salience, Emotion/Negative Emotionality, and Sleep/Circadian Rhythm. The PhAB is meant to be&#xD;
      administered during a Phenotyping visit - an extension of a screening visit in any clinical&#xD;
      trial addictions protocol. In addition to the PhAB, the group also developed an ancillary set&#xD;
      of measures to be administered in conjunction with the PhAB in any addictions clinical trial&#xD;
      during the Phenotyping visit. The Platform Instruments include structured interviews,&#xD;
      diagnostic measures (e.g., MINI), self report scales of symptom severity (e.g., ASRS-ADHD,&#xD;
      VAS-Pain), trauma history (CTQ), computer-administered measures of intelligence (e.g.,&#xD;
      Shipley), and substance use measures (FTND, Timeline Follow-back), etc. Clinical trial&#xD;
      investigators would administer these scales and behavioral tasks in addition to protocol&#xD;
      nonspecific assessments (e.g., demographics) and medical evaluations (e.g, medical history&#xD;
      and physical exams, genotyping, and labs) which could be done at Screening.&#xD;
&#xD;
      This study is a feasibility, construct and face validity study. The primary outcome measure&#xD;
      is time taken to complete the battery, and rates of successful study completion&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 21, 2018</start_date>
  <completion_date type="Actual">March 16, 2020</completion_date>
  <primary_completion_date type="Actual">March 16, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retention</measure>
    <time_frame>1 month</time_frame>
    <description>Number of dropouts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Complete Battery</measure>
    <time_frame>5 hours</time_frame>
    <description>Time to complete the assessment batteries will also be recorded for each task and each participant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-completers of the Battery and Platform Instruments</measure>
    <time_frame>5 hours</time_frame>
    <description>Number of study completers who did not complete the full battery and platform instruments</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Performance on Measures of Cognition Across Conditions</measure>
    <time_frame>5 hours</time_frame>
    <description>Performance (time to complete)&#xD;
#correct) on behavioral tasks which examine cognitive functioning (e.g., Backwards digit span, and stop signal reaction task)</description>
  </other_outcome>
  <other_outcome>
    <measure>Performance on Measures of Reward Processing Across Conditions</measure>
    <time_frame>5 hours</time_frame>
    <description>Performance (time to complete)&#xD;
#correct) on behavioral tasks which examine Reward processing (e.g., hypothetical purchase task) and subscale and total scale scores on self-report measures of reward processing (SUPP-S)</description>
  </other_outcome>
  <other_outcome>
    <measure>Performance on Measures of Negative Emotionality Across Conditions</measure>
    <time_frame>5 hours</time_frame>
    <description>Performance (time to complete)&#xD;
#correct) on behavioral tasks which examine Negative Emotionality (Emotional go/nogo) and subscale and total scale scores on self-report measures of Negative Emotionality (Buss Perry Aggression)</description>
  </other_outcome>
  <other_outcome>
    <measure>Self-report on Measure of Interoception Across Conditions</measure>
    <time_frame>5 hours</time_frame>
    <description>Performance (time to complete)</description>
  </other_outcome>
  <other_outcome>
    <measure>Self-report on Measure of Metacognition Across Conditions</measure>
    <time_frame>5 hours</time_frame>
    <description>Performance (time to complete)</description>
  </other_outcome>
  <other_outcome>
    <measure>Self-report on Measure of Sleep Quality Across Conditions</measure>
    <time_frame>5 hours</time_frame>
    <description>Performance (time to complete)</description>
  </other_outcome>
  <other_outcome>
    <measure>Between-group Differences in Brain Connectivity as Measured by Spectral Dynamic Causal Modeling (DCM) and Deterministic Dynamic Causal Modeling</measure>
    <time_frame>1 month</time_frame>
    <description>Between-group differences in brain connectivity as measured by Spectral dynamic causal modeling (DCM) and Deterministic dynamic causal modeling</description>
  </other_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">368</enrollment>
  <condition>Opioid-use Disorder</condition>
  <condition>Cocaine Use Disorder</condition>
  <condition>Marijuana Use Disorder</condition>
  <condition>Healthy Controls</condition>
  <arm_group>
    <arm_group_label>Individuals with Cocaine Use Disorder</arm_group_label>
    <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Cocaine Use Disorder (n=50).&#xD;
Individuals will be recruited from an existing registry (VCU IRB HMHM20000294, Keyser-Marcus, PI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Individuals with Opioid Use Disorder</arm_group_label>
    <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Opioid Use Disorder (n=200).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Individuals with Marijuana Use Disorder</arm_group_label>
    <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Marijuana Use Disorder (n=50).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>This group will consist of individuals who are determined to be non-drug using healthy controls (n=100).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study utilizes a four-group cross sectional cohort design. A total of 400 participants&#xD;
        (across 4 cohorts) are targeted to complete the study) to include: Healthy Controls&#xD;
        (n=100), individuals with CocUD (n=50), individuals with OUD (n=200), and individuals with&#xD;
        MJUD (n=50).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (Individuals with SUDs)&#xD;
&#xD;
          -  Males and females between 18 and 70 years-of-age.&#xD;
&#xD;
          -  Current DSM-5 primary Substance Use Disorder: Opioid, marijuana, stimulants&#xD;
             (individuals with multiple types of substance use (e.g., opioid/marijuana will be&#xD;
             included)&#xD;
&#xD;
          -  Have no contraindications for study participation as determined by medical history and&#xD;
             concomitant medications.&#xD;
&#xD;
          -  Be able to demonstrate an understanding of study procedures and follow instructions&#xD;
             including behavioral laboratory testing.&#xD;
&#xD;
          -  Be able and willing to comply with scheduled visits, and other study procedures.&#xD;
&#xD;
          -  Be able to read and complete forms and interviews in English.&#xD;
&#xD;
        Inclusion Criteria (Non-drug Using Healthy Controls)&#xD;
&#xD;
          -  Males and females between 18 and 70 years of age.&#xD;
&#xD;
          -  Have no contraindications for study participation as determined by medical history and&#xD;
             concomitant medications.&#xD;
&#xD;
          -  Be able to demonstrate an understanding of study procedures and follow instructions&#xD;
             including behavioral laboratory testing.&#xD;
&#xD;
          -  Be able and willing to comply with scheduled visits, and other study&#xD;
&#xD;
          -  Be able to read and complete forms and interviews in English.&#xD;
&#xD;
        General Exclusion Criteria&#xD;
&#xD;
          -  Current psychosis, mania, or suicidal/homicidal ideation&#xD;
&#xD;
          -  Meet current DSM-5 diagnosis of any psychoactive substance use disorder other than&#xD;
             opioids,marijuana, stimulants, or nicotine. Diagnosis of mild to moderate use disorder&#xD;
             for alcohol will not be considered exclusionary for any SUD group.&#xD;
&#xD;
          -  Have a history of seizures (excluding childhood febrile seizures), or loss of&#xD;
             consciousness from traumatic injury for more than 30 minutes.&#xD;
&#xD;
          -  Have any other illness, or condition, which in the opinion of the PI or study&#xD;
             physician would preclude safe and/or successful completion of the study.&#xD;
&#xD;
        MRI Exclusion Criteria&#xD;
&#xD;
          -  Metal fragments or implants, and/or history of fear of being in closed spaces for MRI&#xD;
             scans.&#xD;
&#xD;
          -  Currently pregnant or nursing.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Lori Keyser-Marcus, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VCU Institute for Drug and Alcohol Studies</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 29, 2018</study_first_submitted>
  <study_first_submitted_qc>April 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2018</study_first_posted>
  <results_first_submitted>July 13, 2021</results_first_submitted>
  <results_first_submitted_qc>July 13, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 4, 2021</results_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Opioid-Related Disorders</mesh_term>
    <mesh_term>Marijuana Use</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 12, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/69/NCT03495869/Prot_SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 22, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/69/NCT03495869/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Individuals With Cocaine Use Disorder</title>
          <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Cocaine Use Disorder (n=50).&#xD;
Individuals will be recruited from an existing registry (VCU IRB HMHM20000294, Keyser-Marcus, PI)</description>
        </group>
        <group group_id="P2">
          <title>Individuals With Opioid Use Disorder</title>
          <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Opioid Use Disorder (n=200).</description>
        </group>
        <group group_id="P3">
          <title>Individuals With Marijuana Use Disorder</title>
          <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Marijuana Use Disorder (n=50).</description>
        </group>
        <group group_id="P4">
          <title>Healthy Controls</title>
          <description>This group will consist of individuals who are determined to be non-drug using healthy controls (n=100).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="124"/>
                <participants group_id="P3" count="61"/>
                <participants group_id="P4" count="129"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="97"/>
                <participants group_id="P3" count="51"/>
                <participants group_id="P4" count="108"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="21"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Dropped from study</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Individuals With Cocaine Use Disorder</title>
          <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Cocaine Use Disorder (n=50).&#xD;
Individuals will be recruited from an existing registry (VCU IRB HMHM20000294, Keyser-Marcus, PI)</description>
        </group>
        <group group_id="B2">
          <title>Individuals With Opioid Use Disorder</title>
          <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Opioid Use Disorder (n=200).</description>
        </group>
        <group group_id="B3">
          <title>Individuals With Marijuana Use Disorder</title>
          <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Marijuana Use Disorder (n=50).</description>
        </group>
        <group group_id="B4">
          <title>Healthy Controls</title>
          <description>This group will consist of individuals who are determined to be non-drug using healthy controls (n=100).</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="97"/>
            <count group_id="B3" value="51"/>
            <count group_id="B4" value="108"/>
            <count group_id="B5" value="306"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.78" spread="8.76"/>
                    <measurement group_id="B2" value="42.49" spread="11.57"/>
                    <measurement group_id="B3" value="35.24" spread="13.10"/>
                    <measurement group_id="B4" value="35.69" spread="14.51"/>
                    <measurement group_id="B5" value="40.77" spread="13.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="64"/>
                    <measurement group_id="B5" value="144"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="52"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="44"/>
                    <measurement group_id="B5" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="46"/>
                    <measurement group_id="B4" value="99"/>
                    <measurement group_id="B5" value="280"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race</title>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="31"/>
                    <measurement group_id="B4" value="42"/>
                    <measurement group_id="B5" value="193"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="47"/>
                    <measurement group_id="B5" value="88"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or not reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="97"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="108"/>
                    <measurement group_id="B5" value="306"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Retention</title>
        <description>Number of dropouts</description>
        <time_frame>1 month</time_frame>
        <population>All participants who signed consent forms and screened eligible were included in the analysis for this outcome variable.</population>
        <group_list>
          <group group_id="O1">
            <title>Individuals With Cocaine Use Disorder</title>
            <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Cocaine Use Disorder (n=50).&#xD;
Individuals will be recruited from an existing registry (VCU IRB HMHM20000294, Keyser-Marcus, PI)</description>
          </group>
          <group group_id="O2">
            <title>Individuals With Opioid Use Disorder</title>
            <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Opioid Use Disorder (n=200).</description>
          </group>
          <group group_id="O3">
            <title>Individuals With Marijuana Use Disorder</title>
            <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Marijuana Use Disorder (n=50).</description>
          </group>
          <group group_id="O4">
            <title>Healthy Controls</title>
            <description>This group will consist of individuals who are determined to be non-drug using healthy controls (n=100).</description>
          </group>
        </group_list>
        <measure>
          <title>Retention</title>
          <description>Number of dropouts</description>
          <population>All participants who signed consent forms and screened eligible were included in the analysis for this outcome variable.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="61"/>
                <count group_id="O4" value="129"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Complete Battery</title>
        <description>Time to complete the assessment batteries will also be recorded for each task and each participant.</description>
        <time_frame>5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Individuals With Cocaine Use Disorder</title>
            <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Cocaine Use Disorder (n=50).&#xD;
Individuals will be recruited from an existing registry (VCU IRB HMHM20000294, Keyser-Marcus, PI)</description>
          </group>
          <group group_id="O2">
            <title>Individuals With Opioid Use Disorder</title>
            <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Opioid Use Disorder (n=200).</description>
          </group>
          <group group_id="O3">
            <title>Individuals With Marijuana Use Disorder</title>
            <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Marijuana Use Disorder (n=50).</description>
          </group>
          <group group_id="O4">
            <title>Healthy Controls</title>
            <description>This group will consist of individuals who are determined to be non-drug using healthy controls (n=100).</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Complete Battery</title>
          <description>Time to complete the assessment batteries will also be recorded for each task and each participant.</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="97"/>
                <count group_id="O3" value="51"/>
                <count group_id="O4" value="108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Time to complete Phenotyping assessment battery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.86" spread="15.77"/>
                    <measurement group_id="O2" value="68.53" spread="16.16"/>
                    <measurement group_id="O3" value="59.76" spread="10.19"/>
                    <measurement group_id="O4" value="61.04" spread="17.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Time to complete battery of Platform Instruments</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.97" spread="38.07"/>
                    <measurement group_id="O2" value="91.24" spread="32.83"/>
                    <measurement group_id="O3" value="75.08" spread="28.67"/>
                    <measurement group_id="O4" value="68.53" spread="24.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Non-completers of the Battery and Platform Instruments</title>
        <description>Number of study completers who did not complete the full battery and platform instruments</description>
        <time_frame>5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Individuals With Cocaine Use Disorder</title>
            <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Cocaine Use Disorder (n=50).&#xD;
Individuals will be recruited from an existing registry (VCU IRB HMHM20000294, Keyser-Marcus, PI)</description>
          </group>
          <group group_id="O2">
            <title>Individuals With Opioid Use Disorder</title>
            <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Opioid Use Disorder (n=200).</description>
          </group>
          <group group_id="O3">
            <title>Individuals With Marijuana Use Disorder</title>
            <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Marijuana Use Disorder (n=50).</description>
          </group>
          <group group_id="O4">
            <title>Healthy Controls</title>
            <description>This group will consist of individuals who are determined to be non-drug using healthy controls (n=100).</description>
          </group>
        </group_list>
        <measure>
          <title>Non-completers of the Battery and Platform Instruments</title>
          <description>Number of study completers who did not complete the full battery and platform instruments</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="97"/>
                <count group_id="O3" value="51"/>
                <count group_id="O4" value="108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Performance on Measures of Cognition Across Conditions</title>
        <description>Performance (time to complete)&#xD;
#correct) on behavioral tasks which examine cognitive functioning (e.g., Backwards digit span, and stop signal reaction task)</description>
        <time_frame>5 hours</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Performance on Measures of Reward Processing Across Conditions</title>
        <description>Performance (time to complete)&#xD;
#correct) on behavioral tasks which examine Reward processing (e.g., hypothetical purchase task) and subscale and total scale scores on self-report measures of reward processing (SUPP-S)</description>
        <time_frame>5 hours</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Performance on Measures of Negative Emotionality Across Conditions</title>
        <description>Performance (time to complete)&#xD;
#correct) on behavioral tasks which examine Negative Emotionality (Emotional go/nogo) and subscale and total scale scores on self-report measures of Negative Emotionality (Buss Perry Aggression)</description>
        <time_frame>5 hours</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Self-report on Measure of Interoception Across Conditions</title>
        <description>Performance (time to complete)</description>
        <time_frame>5 hours</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Self-report on Measure of Metacognition Across Conditions</title>
        <description>Performance (time to complete)</description>
        <time_frame>5 hours</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Self-report on Measure of Sleep Quality Across Conditions</title>
        <description>Performance (time to complete)</description>
        <time_frame>5 hours</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Between-group Differences in Brain Connectivity as Measured by Spectral Dynamic Causal Modeling (DCM) and Deterministic Dynamic Causal Modeling</title>
        <description>Between-group differences in brain connectivity as measured by Spectral dynamic causal modeling (DCM) and Deterministic dynamic causal modeling</description>
        <time_frame>1 month</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 month</time_frame>
      <desc>AE form/log</desc>
      <group_list>
        <group group_id="E1">
          <title>Individuals With Cocaine Use Disorder</title>
          <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Cocaine Use Disorder (n=50).&#xD;
Individuals will be recruited from an existing registry (VCU IRB HMHM20000294, Keyser-Marcus, PI)</description>
        </group>
        <group group_id="E2">
          <title>Individuals With Opioid Use Disorder</title>
          <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Opioid Use Disorder (n=200).</description>
        </group>
        <group group_id="E3">
          <title>Individuals With Marijuana Use Disorder</title>
          <description>This group will consist of individuals who are determined to have DSM5 diagnosis of Marijuana Use Disorder (n=50).</description>
        </group>
        <group group_id="E4">
          <title>Healthy Controls</title>
          <description>This group will consist of individuals who are determined to be non-drug using healthy controls (n=100).</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="108"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="97"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>hospitalization</sub_title>
                <description>Participant was hospitalized to treat cellulitis of a vein that occurred as a result of plasma donation the day prior to study enrollment.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="97"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="108"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="108"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lori Keyser-Marcus, PhD</name_or_title>
      <organization>Virginia Commonwealth University</organization>
      <phone>(804) 828-4164</phone>
      <email>lori.keysermarcus@vcuhealth.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

